Potential early warning system for lung cancer identifiedOctober 11, 2007Autoantibodies in lung cancer: possibilities for early detection and subsequent care An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax. Lung cancer kills around 900,000 people every year, and can take 20 years or more to develop fully. But it is usually only picked up at an advanced stage, when the chances of successful treatment are slim.
As yet, there is no effective early warning system to detect the disease in its early treatable stages, and the dismal long term prospects of patients with lung cancer have changed little in the past 30 years. The research team analysed blood (plasma) samples from 50 healthy volunteers and 104 people with different types of lung cancer. They tested for autoantibodies - immune system proteins directed at the body's own tissues in response to specific chemical signals in the body. They looked in particular for a panel of seven autoantibodies, which are associated with 'solid tumours,' such a lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes are taking place. They found the presence of all seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer. And these autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, the body's gatekeepers. This indicates that the disease had not yet spread elsewhere and offers an 80% chance of a cure. Only one healthy volunteer had more than one of these autoantibodies in their blood. Other research has indicated that these autoantibodies can be picked up as early as five years before clinical symptoms start to show. In a previous study, the researchers found abnormally high levels of specific autoantibodies in patients with breast cancer, prompting them to suggest that a test for these could be added to the screening programme. That study also showed that these autoantibodies were present before clinical symptoms appeared.. The authors argue that the lungs are especially sensitive to radiation, so repeated chest x-rays are not ideal for picking up lung cancer. A blood test, on the other hand, is cheap compared with imaging techniques, and has no side effects. And the panel can be changed to include more or different autoantibodies for lung and other cancers. They suggest that the blood test could be used for people at increased risk of developing the disease, such as smokers and passive smokers. If they test positive, these people could then be referred for more detailed scans, such as computed tomography (CT) or magnetic resonance imaging (MRI), they suggest. BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Autoantibodies Current Events and Autoantibodies News Articles A reversal of thinking: How women with lupus can increase chance for healthy pregnancies In the not so distant past, women with systemic lupus erythematosus (SLE), an autoimmune disease, were advised not to have children, and if they became pregnant, to have therapeutic abortions to prevent severe flares of their lupus. Green tea may delay onset of type 1 diabetes A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. Mediator in communication between neurons and muscle cells found A missing piece of the puzzle of how neurons and muscle cells establish lifelong communication has been found by researchers who suspect this piece may be mutated and/or attacked in muscular dystrophy. Protein complementarity may offer new insights into autoimmune diseases The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December Journal of the American Society of Nephrology (JASN). Targeted drug therapy found effective in patients with common form of immune-mediated kidney disease The drug rituximab causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study appearing in the November 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that this condition, previously destined to progress to kidney failure in 30-40 percent of cases, can actually be healed in some patients. New research on pre-eclampsia in mice may have important implications for humans In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans. Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases The TRAF1/C5 locus on chromosome 9 has been revealed to play a role in multiple autoimmune diseases including type 1 diabetes and systemic lupus erythematosus (SLE). Lupus more severe in patients with Southern European ancestry ystemic lupus erythematosus (SLE) patients with a higher percentage of ancestry from southern Europe have more severe disease manifestations, according to new research presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. Common bacteria activating natural killer T cells may cause autoimmune liver disease A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Genes linked with lupus are revealed, giving hope for new treatments Scientists have identified a number of genes involved in Lupus, a devastating autoimmune disease, in new research published today in the journal Nature Genetics. More Autoantibodies Current Events and Autoantibodies News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||